Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda.
Cobelens
Frank G J
FG
KNCV Tuberculosis Foundation, The Hague, The Netherlands. cobelensf@kncvtbc.nl
Heldal
Einar
E
Kimerling
Michael E
ME
Mitnick
Carole D
CD
Podewils
Laura J
LJ
Ramachandran
Rajeswari
R
Rieder
Hans L
HL
Weyer
Karin
K
Zignol
Matteo
M
D000995:Antitubercular Agents / Q000627:therapeutic use*; D014943:Global Health; D006801:Humans; D012106:Research; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*
D000995:Antitubercular Agents